Brookwood Pharmaceuticals , Inc.

Rating: 0/5 - Write A Review
756 Tom Martin Drive
Birmingham, AL 35211

About Brookwood Pharmaceuticals , Inc.

Brookwood Pharmaceuticals, Inc. is focused on drug delivery, clinical trial manufacturing and biomaterials. Brookwood has a wide-range of delivery technologies particularly for long-acting parenterals such as injectable microparticles and injectable solid implants to deliver small molecules, peptides, proteins, and nucleic acids. Partnered programs range from feasibility studies, product development and optimization, process scale up, clinical trial manufacturing of drug-delivery formulations, such as liposomes, microparticles and other long acting parenterals. Lakeshore Biomaterials, a division of Brookwood Pharmaceuticals manufactures poly(lactide-co-glycolide) and other biomaterials. Brookwood Pharmaceuticals is a SurModics company.

Competitors of Brookwood Pharmaceuticals , Inc.

HERMES PHARMA GmbH

HERMES PHARMA is the leading expert in developing and manufacturing user-friendly oral dosage forms. As a CDMO, we offer customized services along the entire pharmaceutical value chain, from new product development and formulation to manufacturing and regulatory support. For more than 40 years,... Read More

  • write a review

UPM Pharmaceuticals Inc

UPM Pharmaceuticals Inc., a trailblazing contract development and manufacturing organization (CDMO), emerges as a beacon of innovation and excellence in the pharmaceutical manufacturing industry. Anchored in our ethos of integrity and quality, we are an independent, family-owned enterprise that... Read More

  • write a review

ProJect Pharmaceutics GmbH

ProJect Pharmaceutics is one of the leading European CRO service providers specialized in formulation and manufacturing process development for parenteral drug products, including biologics (rec. proteins, antibodies, fusion proteins), peptides, ADCs, cytotoxics, small molecules, generics, viral... Read More

9/17/24- Pharm Mfg. - MR
Pharma_3:1_8.14.19
9/17/24- Pharm Mfg. - MR
Pharma_3:1_8.14.19